secwatch.observer — SEC 8-K summary
======================================

Issuer:     KALA BIO, Inc. (KALA)
CIK:        0001479419
Form:       8-K
Filed at:   2023-06-23T23:59:59+00:00
Accession:  0001558370-23-011375
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kala shareholders approve equity plan increase, reject name change at annual meeting
--------------------------------------------------------------------------------

- Approved A&R 2017 Equity Incentive Plan; adds 1.25M shares, extends term to June 2033.
- Elected C. Daniel Myers and Howard B. Rosen as Class III directors for three-year terms.
- Advisory vote on executive compensation passed (498,054 for, 57,912 against); frequency set every year.
- Proposal to rename to 'Kala Bio, Inc.' did not receive required votes; 1.15M for vs 11,194 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479419/000155837023011375/0001558370-23-011375-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479419/000155837023011375/kala-20230622x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-011375

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer